Evidence map›Paper›PMID 40726443›Full record

ArticleEuropean journal of public health2025

Targeting under-screened women in cervical cancer: combining self-sampling and human papillomavirus testing with a strategic reminder plan.

Sara da Graça Pereira, Luís Nobre, Marina Ribeiro, Patrícia Carvalho, Ana Morais, Rita Sousa, Ana Paula Moniz, Francisco Matos, Graça Fernandes, João Pedro Pimentel and 8 more

Abstract read
In one paragraph

Article in European journal of public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Sara da Graça PereiraInfogene, IPN Aceleradora, Coimbra, Portugal.
Luís NobreInfogene, IPN Aceleradora, Coimbra, Portugal.
Marina RibeiroInfogene, IPN Aceleradora, Coimbra, Portugal.
Patrícia CarvalhoDepartment of Public Health, Central Regional Health Administration (ARS Centro), Coimbra, Portugal.
Ana MoraisWorking Group on Cervical Cancer in the Central Region of Portugal (GTCCU), Central Regional Health Administration (ARS Centro), Coimbra, Portugal.
Rita SousaWorking Group on Cervical Cancer in the Central Region of Portugal (GTCCU), Central Regional Health Administration (ARS Centro), Coimbra, Portugal.
Ana Paula MonizWorking Group on Cervical Cancer in the Central Region of Portugal (GTCCU), Central Regional Health Administration (ARS Centro), Coimbra, Portugal.
Francisco MatosDepartment of Public Health, Central Regional Health Administration (ARS Centro), Coimbra, Portugal.
Graça FernandesWorking Group on Cervical Cancer in the Central Region of Portugal (GTCCU), Central Regional Health Administration (ARS Centro), Coimbra, Portugal.
João Pedro PimentelDepartment of Public Health, Central Regional Health Administration (ARS Centro), Coimbra, Portugal.
José Carlos MarinhoWorking Group on Cervical Cancer in the Central Region of Portugal (GTCCU), Central Regional Health Administration (ARS Centro), Coimbra, Portugal.
José Luís SáWorking Group on Cervical Cancer in the Central Region of Portugal (GTCCU), Central Regional Health Administration (ARS Centro), Coimbra, Portugal.
Olga IlhéuWorking Group on Cervical Cancer in the Central Region of Portugal (GTCCU), Central Regional Health Administration (ARS Centro), Coimbra, Portugal.
Teresa RebeloWorking Group on Cervical Cancer in the Central Region of Portugal (GTCCU), Central Regional Health Administration (ARS Centro), Coimbra, Portugal.
José Fonseca-MoutinhoWorking Group on Cervical Cancer in the Central Region of Portugal (GTCCU), Central Regional Health Administration (ARS Centro), Coimbra, Portugal.
Hugo PrazeresInfogene, IPN Aceleradora, Coimbra, Portugal.
Rui Jorge NobreCenter for Neuroscience and Cell Biology (CNC), Centre for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal.ORCID 0000-0001-5816-2051
Fernanda LoureiroDepartment of Public Health, Central Regional Health Administration (ARS Centro), Coimbra, Portugal.

Funding

InfogenePortuguese Institute of Oncology at Coimbra
6 · The paper itself

Abstract

Cervical cancer (CC) screening is essential for reducing its incidence, yet engaging under-screened women remains challenging. Self-sampling has emerged as a promising solution to enhance attendance; however, its integration into programmes has proven difficult. This study evaluated a multimodal approach combining self-sampling, human papillomavirus (HPV) testing, and personalized contact to reach women not attending conventional CC screening. To achieve this, 801 women aged 30-59 who had not participated in Portugal's Central Region CC screening programme for more than 4 years were selected based on specific criteria. Of these, 114 women were excluded for not meeting eligibility criteria, resulting in 687 eligible participants. Using an 'opt-in' approach, women who consented to participate received cervicovaginal self-sampling kits at home. Multiple contact strategies, including phone calls and reminder letters, were employed to encourage participation. Women testing positive for high-risk HPV (hr-HPV) were referred for gynaecological follow-up. Of the eligible women, 307 (44.7%) consented to participate and 198 (28.8%) provided valid samples for hr-HPV testing. Approximately 60.0% of participants were enrolled after the first reminder phone call, while additional contact strategies accounted for one-third of submitted samples. Among 12 hr-HPV positive cases, 11 completed gynaecological follow-up, resulting in the identification of six cervical lesions. This study confirms the feasibility and effectiveness of combining self-sampling, HPV testing, and personalized contact strategies to improve CC screening uptake among under-screened women. The findings highlight the potential of such interventions to address participation gaps and enhance early detection of cervical lesions, ultimately reducing CC incidence.

Indexed as

Early Detection of CancerMass ScreeningPapillomavirus InfectionsReminder SystemsSelf CareUterine Cervical NeoplasmsVaginal SmearsAdultFemaleHuman Papillomavirus VirusesHumansMiddle AgedPapillomaviridaePortugalSpecimen Handling

Identifiers

PMID40726443
PMCPMC12529258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.